1. Home
  2. GNT vs COYA Comparison

GNT vs COYA Comparison

Compare GNT & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GAMCO Natural Resources Gold & Income Trust

GNT

GAMCO Natural Resources Gold & Income Trust

HOLD

Current Price

$8.19

Market Cap

128.7M

Sector

Finance

ML Signal

HOLD

Logo Coya Therapeutics Inc.

COYA

Coya Therapeutics Inc.

HOLD

Current Price

$4.51

Market Cap

124.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GNT
COYA
Founded
2011
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
128.7M
124.8M
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
GNT
COYA
Price
$8.19
$4.51
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$15.80
AVG Volume (30 Days)
129.2K
262.1K
Earning Date
01-01-0001
05-08-2026
Dividend Yield
6.61%
N/A
EPS Growth
N/A
N/A
EPS
0.95
N/A
Revenue
N/A
$7,945,753.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$763.10
P/E Ratio
$8.62
N/A
Revenue Growth
N/A
123.57
52 Week Low
$6.22
$3.71
52 Week High
$9.30
$7.75

Technical Indicators

Market Signals
Indicator
GNT
COYA
Relative Strength Index (RSI) 48.56 37.25
Support Level $8.17 $4.45
Resistance Level $8.35 $5.18
Average True Range (ATR) 0.08 0.39
MACD 0.00 -0.15
Stochastic Oscillator 52.50 5.08

Price Performance

Historical Comparison
GNT
COYA

About GNT GAMCO Natural Resources Gold & Income Trust

GAMCO Natural Resources, Gold & Income Trust is a non-diversified closed-end management investment company. The company's primary investment objective is to provide a high level of current income from interest, dividends, and options premiums with its secondary objective being capital appreciation. Under normal market conditions, the company invests majority of its assets in securities of companies principally engaged in the natural resources and gold industries, and also engages in writing covered call options on the underlying equity securities. Its portfolio consists of securities from different sectors such as metals and mining, energy and energy services, specialty chemicals, agriculture, healthcare, machinery, food and beverage, and others.

About COYA Coya Therapeutics Inc.

Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells (Tregs). The company's initial development programs are focused on neurodegenerative, chronic inflammatory, autoimmune, and metabolic diseases with high unmet medical needs.

Share on Social Networks: